Pages that link to "Q33349831"
Jump to navigation
Jump to search
The following pages link to Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries (Q33349831):
Displaying 50 items.
- Atypical hemolytic uremic syndrome (Q21202864) (← links)
- Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes (Q24313395) (← links)
- Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II) (Q24317382) (← links)
- Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome (Q24543850) (← links)
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome (Q24634697) (← links)
- Pathogenesis of thrombotic microangiopathies (Q24658043) (← links)
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome (Q24685473) (← links)
- Advances and challenges in the management of complement-mediated thrombotic microangiopathies (Q26796453) (← links)
- Atypical haemolytic uraemic syndrome associated with a hybrid complement gene (Q28766922) (← links)
- The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. (Q30377280) (← links)
- Genetic screening in haemolytic uraemic syndrome (Q33357183) (← links)
- Familial haemolytic uraemic syndrome and an MCP mutation (Q33357579) (← links)
- Atypical relapse of hemolytic uremic syndrome after transplantation (Q33362060) (← links)
- Atypical haemolytic uraemic syndrome and mutations in complement regulator genes (Q33368691) (← links)
- An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations (Q33369200) (← links)
- A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H. (Q33369638) (← links)
- Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome. (Q33369997) (← links)
- Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. (Q33370511) (← links)
- Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation (Q33372160) (← links)
- Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management? (Q33372382) (← links)
- Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome (Q33372850) (← links)
- Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate (Q33374215) (← links)
- Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development (Q33374478) (← links)
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains (Q33375335) (← links)
- Pathogenesis and prognosis of thrombotic microangiopathy (Q33375692) (← links)
- Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism. (Q33375818) (← links)
- Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. (Q33377223) (← links)
- Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degen (Q33377284) (← links)
- Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis (Q33377727) (← links)
- Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. (Q33377799) (← links)
- Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. (Q33378236) (← links)
- The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome (Q33378469) (← links)
- What's new in haemolytic uraemic syndrome? (Q33380073) (← links)
- Complement and the atypical hemolytic uremic syndrome in children. (Q33380163) (← links)
- Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome (Q33381980) (← links)
- The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci (Q33384198) (← links)
- Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency (Q33385035) (← links)
- A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure (Q33385329) (← links)
- Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. (Q33387252) (← links)
- Genetics and complement in atypical HUS. (Q33389945) (← links)
- Living donor kidney transplantation in patients with hereditary nephropathies (Q33392071) (← links)
- Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities (Q33393852) (← links)
- Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report (Q33395870) (← links)
- Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance (Q33396948) (← links)
- Age-related penetrance of hereditary atypical hemolytic uremic syndrome (Q33397115) (← links)
- Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations (Q33398546) (← links)
- STEC-HUS, atypical HUS and TTP are all diseases of complement activation (Q33403359) (← links)
- Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). (Q33406356) (← links)
- Complement therapy in atypical haemolytic uraemic syndrome (aHUS). (Q33408733) (← links)
- De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus (Q33419720) (← links)